Eltoprazine counteracts l-DOPA-induced dyskinesias in Parkinson’s disease: a dose-finding study

In advanced stages of Parkinson’s disease, serotonergic terminals take up l-DOPA and convert it to dopamine. Abnormally released dopamine may participate in the development of l-DOPA-induced dyskinesias. Simultaneous activation of 5-HT1A and 5-HT1B receptors effectively blocks l-DOPA-induced dyskine...

Descripción completa

Detalles Bibliográficos
Autores principales: Svenningsson, Per, Rosenblad, Carl, af Edholm Arvidsson, Karolina, Wictorin, Klas, Keywood, Charlotte, Shankar, Bavani, Lowe, David A., Björklund, Anders, Widner, Håkan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5014080/
https://www.ncbi.nlm.nih.gov/pubmed/25669730
http://dx.doi.org/10.1093/brain/awu409

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5014080/
https://www.ncbi.nlm.nih.gov/pubmed/25669730
http://dx.doi.org/10.1093/brain/awu409

Ejemplares similares